ArticleClinical kidney journal2026

Twelve-month real-world outcomes of sparsentan in a multicenter Spanish IgA nephropathy cohort.

Clara García-Carro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.